M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring

Short descriptor: Bamlan and etesev infusion

⚠ Terminated HCPCS Level II 2026
Terminated Code
M0245 was terminated as of 2023-12-13 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M0245 in the app →

Look up M0245 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M0245 is the HCPCS Level II code for Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Vaccinations (indicator 54)
Type of Service
Pneumococcal/flu/hepatitis B vaccine
Effective Date
2023-12-14
Termination Date
2023-12-13
2026 Maintenance
No change this year

References

Cite This Page

Reference M0245 with the canonical source and edition:

M0245 — Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M0245

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M0245

Related Codes in Section M

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial